Abstract
Purpose
Gastric cancer (GC) is a major tumor throughout the world with remaining high morbidity and mortality. The aim is to generate a gene model to assess the prognoses risk of patients with GC.
Methods
Gene expression profiling of gastric cancer patients, GSE62254 (300 samples) and GSE26253 (432 samples), was downloaded from Gene Expression Omnibus (GEO) database. Univariate survival analysis and LASSO (Least Absolute Shrinkage and Selectionator operator) (1000 iterations) of differentially expressed genes in GSE62254 was assessed using survival and glmnet in R package, respectively. Kaplan–Meier analysis on the clustering algorithm from each regression model was performed to calculate the influence to the prognosis. Random samples in GSE26253 were analyzed in multivariate and univariate survival analysis for one thousand times to calculate statistical stability of each regression model.
Results
A total of 854 Genes were identified differentially expressed in GSE62254, among which 367 Genes were found influencing the prognoses. Six gene clusters were selected with good stability. Hereinto, five or more genes in 11-Gene model, TRPC1, SGCE, TNFRSF11A, LRRN1, HLF, CYS1, PPP1R14A, NOV, NBEA, CES1 and RGN, was available to evaluate the prognostic risk of GC patients in GSE26253 (P = 0.00445). The validity and reliability was validated.
Conclusion
In conclusion, we successfully generated a stable 5-Gene model, which could be utilized to predict prognosis of GC patients and would contribute to postoperational treatment and follow-up strategies.
Similar content being viewed by others
References
Catalano V et al (2009) Gastric cancer. Crit Rev Oncol Hematol 71(2):127–164
Chen W et al (2015) The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer 34(11):502–507
Chen T, Xu XY, Zhou PH (2016) Emerging molecular classifications and therapeutic implications for gastric cancer. Chin J Cancer 35(1):49
Cristescu R et al (2015) Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med 21(5):449–456
Ferlay J et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1):1–22
Heagerty PJ, Lumley T, Pepe MS (2000) Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 56(2):337–344
Hooi WC (2009) The role of ROS-mediated ERK and JNK activation in the induction of autophagy and apoptosis in tumour cells by a novel small molecule compound. Ph D
Hossain MS et al (2008) N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma. Oncogene 27(46):6075–6082
Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
Jia ZF et al (2016) CD24-Genetic variants contribute to overall survival in patients with gastric cancer. World J Gastroenterol 22(7):2373–2382
Kennedy NJ, Davis RJ (2003) Role of JNK in tumor development. Cell Cycle 2(3):199–201
Lee J et al (2014) Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. PLoS ONE 9(3):e90133
Lu X et al (2015) Detection and clinical significance of COX-2-Gene SNPs in gastric cancer. Cell Biochem Biophys 72(3):657–660
Mathers C, Fat DM, Boerma JT (2008) The global burden of disease: 2004 update. World Health Organization, Geneva
McAvoy S et al (2007) Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res 118(2–4):260–269
O’Neal J et al (2009) Neurobeachin (NBEA) is a target of recurrent interstitial deletions at 13q13 in patients with MGUS and multiple myeloma. Exp Hematol 37(2):234–244
O’Quigley J, Moreau T (1986) Cox’s regression model: computing a goodness of fit statistic. Comput Methods Progr Biomed 22(3):253–256
Paria BC et al (2003) Tumor necrosis factor-alpha induces nuclear factor-kappaB-dependent TRPC1 expression in endothelial cells. J Biol Chem 278(39):37195–37203
Skierucha M et al (2016) Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 22(8):2460–2474
Sordillo EM, Pearse RN (2003) RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. Cancer 97(3 Suppl):802–812
Stahl P et al (2015) Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer. BMC Gastroenterol 15:7
Veeriah S et al (2014) High-throughput time-resolved FRET reveals Akt/PKB activation as a poor prognostic marker in breast cancer. Cancer Res 74(18):4983–4995
von dem Knesebeck A et al (2012) RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas. Neoplasia 14(6):526–534
Wang T et al (2016) Interleukin (IL)-4-590C>T polymorphism is not associated with the susceptibility of gastric cancer: an updated meta-analysis. Ann Med Surg (Lond) 9:1–5
Xu CJ et al (2012a) Impact of statistical learning methods on the predictive power of multivariate normal tissue complication probability models. Int J Radiat Oncol Biol Phys 82(4):e677–e684
Xu CJ et al (2012b) Statistical validation of normal tissue complication probability models. Int J Radiat Oncol Biol Phys 84(1):e123–e129
Tibshirani R (1997) The lasso method for variable selection in the cox model. Stat Med 16:385–395
Yang L (2006) Incidence and mortality of gastric cancer in China. World J Gastroenterol 12(1):17–20
Yang X, Takano Y, Zheng HC (2012) The pathobiological features of gastrointestinal cancers (review). Oncol Lett 3(5):961–969
Zabaleta J (2012) Multifactorial etiology of gastric cancer. Methods Mol Biol 863:411–435
Zeng H et al (2015) Cancer survival in China, 2003-2005: a population-based study. Int J Cancer 136(8):1921–1930
Zhi-Gao XU et al (2012) Expression and clinical significance of HER-2 and NF-κB in gastric cancer. Prog Mod Biomed 21:004
Zhou F et al (2016) Associations of potentially functional variants in IL-6, JAKs and STAT3 with gastric cancer risk in an eastern Chinese population. Oncotarget
Funding
This study was supported by the SUMHS collaborative innovation focus (HMCI-16-11-004).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All authors declared no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Jun-Yi Hou, Yu-Gang Wang and Shi-Jie Ma: co-first authors.
Rights and permissions
About this article
Cite this article
Hou, JY., Wang, YG., Ma, SJ. et al. Identification of a prognostic 5-Gene expression signature for gastric cancer. J Cancer Res Clin Oncol 143, 619–629 (2017). https://doi.org/10.1007/s00432-016-2324-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-016-2324-z